Aditxt, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Aditxt, Inc. (ADTX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $389.17 thousand as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-05-20
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $389.17K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $801.76K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $423.93K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $423.93K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-03-31 | $389.17K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $801.76K 10-K · filed 2026-03-31 |
| 2025-09-30 | $423.93K 10-Q · filed 2025-11-18 |
| 2025-06-30 | $423.93K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $423.93K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $710.55K 10-K · filed 2025-03-31 |
| 2024-09-30 | $710.55K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $710.55K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $710.55K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $1.00M 10-K · filed 2024-04-16 |
| 2023-09-30 | $285.99K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $570.63K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $851.88K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.13M 10-K · filed 2023-04-17 |
| 2021-03-31 | $305.20K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $406.64K 10-K · filed 2021-03-25 |
| 2020-09-30 | $84.54K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |